非小细胞肺癌组织标本与配对胸腔积液细胞块PD-L1检测一致性研究
本研究回顾性纳入115例非小细胞肺癌患者,其中82例胸腔积液细胞块含至少100个肿瘤细胞并进行分析,比较组织标本与配对胸腔积液细胞块的PD-L1免疫组化结果。结果显示,两者分类为阴性、中度阳性或强阳性时的加权kappa为0.76(95%CI:0.64-0.88),一致性为0.78(95%CI:0.68-0.86),提示相关性高,无法进行组织活检的患者可考虑胸腔积液PD-L1检测。
要点
- 组织标本与配对胸腔积液细胞块PD-L1检测高度一致。
- 加权kappa为0.76,一致性为0.78。
- 无法组织活检者可考虑胸腔积液PD-L1检测。
核心结论
- 组织标本与配对胸腔积液细胞块的PD-L1检测相关性和一致性均高。
- 无法进行组织活检的患者应考虑胸腔积液PD-L1评估。
研究设计与样本
- 回顾性队列研究,纳入接受肺肿块核心活检或手术切除并具有PD-L1免疫组化结果、且胸腔积液细胞块可用于PD-L1染色的NSCLC患者。
- 共纳入115例患者,其中82例(71.3%)胸腔积液细胞块含至少100个肿瘤细胞并纳入分析,80例(97.6%)为腺癌。
主要发现
- 组织标本与胸腔积液细胞块PD-L1分类为阴性、中度阳性或强阳性时,加权kappa为0.76(95%CI:0.64-0.88)。
- 组织标本与胸腔积液细胞块PD-L1一致性为0.78(95%CI:0.68-0.86)。
关键数值与推荐
- PD-L1阴性定义为肿瘤细胞PD-L1<1%。
- PD-L1中度阳性定义为肿瘤细胞PD-L1≥1%且<50%。
- PD-L1强阳性定义为肿瘤细胞PD-L1≥50%。
- 胸腔积液细胞块肿瘤细胞<100个定义为PD-L1检测不合格。
临床怎么用
- 对于无法进行组织活检的NSCLC患者,可考虑采用胸腔积液细胞块进行PD-L1免疫组化检测以指导抗PD-L1/PD-L1治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Analysis of programmed death ligand-1 (PD-L1) in tumour samples is necessary to identify candidates for anti-PD-L1/PD-L1 therapy. Because PD-L1 is evaluated by immunohistochemistry (IHC), an adequate amount of tumour tissue is a prerequisite for PD-L1 testing. To examine whether pleural fluid might be an alternative to biopsy/resection specimens for IHC evaluation of PD-L1 in patients with non-small cell lung carcinoma (NSCLC), we compared PD-L1 by IHC between histological specimens and matched pleural fluid. METHODS: A retrospective cohort study of patients with NSCLC who underwent core biopsy of a lung mass/surgical resection with PD-L1 IHC and had a pleural fluid cell block (CB) available for PD-L1 staining was conducted. PD-L1 was categorized as negative (PD-L1 in <1% of tumour cells), moderately positive (PD-L1 in ≥1% to <50%), strongly positive (PD-L1 ≥ 50) or inadequate for PD-L1 testing (<100 tumour cells in the CB). Weighted Cohen's kappa was calculated to evaluate the agreement between PD-L1 on biopsy/resection specimen and pleural fluid for variables with more than two categories. RESULTS: Of the 115 patients included in this study, 82 (71.3%) had at least 100 tumour cells and were included in the analysis. Of these, 80 (97.6%) had adenocarcinoma. For PD-L1 of histological specimens versus pleural fluid categorized as negative, moderately positive or strongly positive, the weighted kappa statistic was 0.76 (95% CI: 0.64-0.88), and the concordance was 0.78 (95% CI: 0.68-0.86). CONCLUSION: Correlation and concordance are high between PD-L1 in histological specimens and matched pleural fluid. Evaluation of PD-L1 in pleural fluid should be considered in patients unable to undergo histological biopsies.
引用
- Grosu HB, Arriola A, Stewart J, et al. PD-L1 detection in histology specimens and matched pleural fluid cell blocks of patients with NSCLC. Respirology. 2019. PMID: 31209954. doi:10.1111/resp.13614
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。